Vaxart Inc. (NASDAQ:VXRT) finished Thursday with a subtraction of -$0.01 to close at $7.09, a downside of -0.14 percent. An average of 5,211,240 shares of common stock have been traded in the last five days. There was a fall of -$0.86 in the past week. The last 20 days have seen an average of 3,582,955 shares traded, while the 50-day average volume stands at 6,484,566.
VXRT stock has decreased by -17.75% in the last month. The company shares reached their 1-month lowest point of $6.69 on 10/04/21. With the stock rallying to its 52-week high on 02/02/21, shares of the company touched a low of $3.50 and a high of $24.90 in 52 weeks. In spite of this, the price is down -71.53% from the 52-week high.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
28 days have passed since Vaxart Inc. (VXRT) last reported insider trading activity. Echerd Margaret, who is SVP, Principal Accntng Officer, most recently acquired $1,801 shares at $9.10 per share on Sep 10. In this transaction, the insider spent $16,389. SVP, Principal Accntng Officer, Echerd Margaret, disposed of 1,801 shares at a price of $10.00 on Aug 10. The insider now owns more than $18,010 worth of shares. Prior to that, SVP, Chief Scientific Officer Tucker Sean went on to Sale 5,828 shares at $10.20 each on Aug 10. An amount of $59,446 was transacted.
Vaxart Inc. (VXRT) has a trailing price-to-earnings (P/E) ratio of 34.65 for the broader industry and 32.11 for the sector. This means investors are optimistic about the stock’s future prospects. The stock’s beta is 0.47. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 819.49, the price-to-book (PB) ratio at 4.30.
The quick ratio of Vaxart Inc. for the three months ended June 29 was 14.80, and the current ratio was 14.80, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 For the recent quarter ending June 29. Vaxart Inc.’s EBITDA margin for the year ending June 29 is -721.03%. Its gross profit as reported stood at $34.22 million compared to revenue of $4.05 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Vaxart Inc.’s return on assets was -29.10%. For the broader industry, ROE averaged -68.79 over the past year.
For the three-month period that ended June 29, Vaxart Inc. had $19.32 million in cash. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of $0.11 million in the quarter, while revenues of $0.51 million were shrunk -372.73%. The analyst consensus anticipated Vaxart Inc.’s latest quarter earnings to come in at -$0.14 per share, but it turned out to be -$0.13, a 7.10% surprise. For the recent quarter, EBITDA amounted to -$14.76 million. Shareholders own equity worth $122.82 million.
From a technical analysis perspective, let’s take a brief look at Vaxart Inc. (VXRT) price momentum. RSI 9-day as of the close on 07 October was 31.96%, suggesting the stock is Neutral, with historical volatility in this time frame at 73.75%.
As of today, VXRT’s price is $7.13 -10.82% or -$0.86 from its 5-day moving average. VXRT is currently trading -21.48% lower than its 20-day SMA and +10.26% higher than its 100-day SMA. However, the stock’s current price level is -13.64% below the SMA50 and -7.32% below the SMA200.
The stochastic %K and %D were 26.30% and 24.33%, respectively, and the average true range (ATR) was 0.44. With the 14-day stochastic at 22.22% and the average true range at 0.46, the RSI (14) stands at 35.86%. The stock has reached -0.37 on the 9-day MACD Oscillator while the 14-day reading was at -0.59.
B. Riley Securities downgraded Vaxart Inc. (NASDAQ: VXRT) to a a Neutral rating in its most recent analyst report. Previously, the stock was rated as a a Buy.The consensus rating for Vaxart Inc. (VXRT) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell VXRT, while 1 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 3 others rate it as a “buy”.
What is VXRT’s price target for the next 12 months?
Analysts predict a range of price targets between $9.00 and $18.00, with a median target of $11.50. Taking a look at these predictions, the average price target given by analysts for Vaxart Inc. (VXRT) stock is $12.50.